Investor Portal
Advancing the Science of Neuromodulation

Evidence-Based Tinnitus Treatment Device

Neuromod has the largest body of clinical trials and real world evidence for any tinnitus treatment device supporting the efficacy, safety and patient compliance of bimodal neuromodulation.

Spotlight: Lenire Controlled Clinical Trial

Peer-Reviewed and Published in Nature Communications

Nature Communications published TENT-A3, a controlled clinical trial for Lenire that was pivotal in the tinnitus treatment device being awarded a De Novo FDA Approval grant.2

SPOTLIGHT: REAL WORLD EVIDENCE PUBLISHED IN NATURE

Bimodal Effective For Real World Tinnitus Patients

Nature Communications Medicine published the first ever real world review of 220 tinnitus patients treated using Lenire’s bimodal neuromodulation approach.3

Published Clinical Trial Papers

TENT-A1

80% of Lenire’s first clinical trial patients had a reduction in tinnitus severity that sustained for at least 12 months after treatment.

TENT-A2

91% of Lenire’s second clinical trial patients had a reduction in tinnitus severity that sustained for at least 12 months after treatment.

TENT-A3

Majority of patients with moderate or worse tinnitus had significant relief using Lenire when sound-only had no meaningful impact.

TAVVS Research Paper

An Investigation of Feasibility and Safety of Bi-Modal Stimulation for the Treatment of Tinnitus: An Open-Label Pilot Study.

Protocol Papers & Supplementary Materials

TENT-A1 Supplementary Materials

Supplementary Materials for Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study

TENT-A2 Supplementary Materials

Supplementary Materials for Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial

TENT-A1 Protocol Paper

Bi-modal stimulation in the treatment of tinnitus: a study protocol for an exploratory trial to optimise stimulation parameters and patient subtyping.

TENT-A2 Protocol Paper

Noninvasive Bimodal Neuromodulation for the Treatment of Tinnitus: Protocol for a 2nd Large-Scale Double-Blind Randomized Clinical Trial.

Additional Research Papers

Hannover Real World Evidence

86.2% of treatment compliant patients had a clinically meaningful reduction in tinnitus.

Hearing Aids & Lenire Paper

92% of hearing aid users said they found Lenire to be beneficial in real world review.

Find a Lenire Clinic

Lenire is available in more than 130 clinics across the United States of America and Europe. Book an appointment with a leading tinnitus expert and start your tinnitus treatment journey.

Find a Lenire Provider

Stay in the Loop

Register for the Neuromod Newsletter to stay up to date on hearing and tinnitus industry news, emerging tinnitus research, and all things Neuromod and Lenire.

Subscribe